Eric Chung1, Matthew Solomon, Ling DeYoung, Gerald B Brock. 1. Division of Urology, St Joseph's Health Care, London, ON, Canada Department of Urology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Abstract
INTRODUCTION: The implantation of inflatable penile prosthesis (IPP) with simultaneous manual penile remodeling allows for men to undergo a single procedure aimed at correcting both the penile deformity/curvature and erectile dysfunction (ED). AIM: To evaluate the clinical outcomes and patient satisfaction in men with Peyronie's disease (PD) and ED who underwent AMS 700™ CX and the newer Coloplast™ Titan inflatable penile prosthesis (IPP) implant. MAIN OUTCOME MEASURES: Patient demographics, type of IPP, clinical outcomes, post-implant sexual characteristics, and overall patient satisfaction. METHODS: A single-center retrospective review of clinical database and prospective telephone survey were conducted in all men with PD who underwent IPP between January 2006 and November 2010. RESULTS: A total of 138 patients with an average age of 57.7 (32 to 80) underwent AMS 700 CX (88 patients) and Coloplast Titans (50 patients) IPP implantation during the 5-year period. The majority of patients (91%) had only one IPP implantation. The IPP clinical outcomes include eight (6%) revision surgery for device malfunction and three (2%) device explantation for prosthesis infection. While there was no statistically significance in device survival between the two devices, the trend favored AMS 700 CX over Titan (5-year Kaplan-Meier estimates of mechanical survival were 91% vs. 87%, P>0.05) and both IPPs provided similar penile straightening without the need for revision surgery. Most men (79%) reported great satisfaction following CX or Titan implants with greater than two thirds of men reported greater self-confidence and 82% of patients would undergo the same operation again. CONCLUSIONS: AMS 700™ CX and Coloplast™ Titan IPP implantation and penile remodeling appeared to provide permanent penile straightening and high patient satisfaction without an increase risk of revision surgery.
RCT Entities:
INTRODUCTION: The implantation of inflatable penile prosthesis (IPP) with simultaneous manual penile remodeling allows for men to undergo a single procedure aimed at correcting both the penile deformity/curvature and erectile dysfunction (ED). AIM: To evaluate the clinical outcomes and patient satisfaction in men with Peyronie's disease (PD) and ED who underwent AMS 700™ CX and the newer Coloplast™ Titan inflatable penile prosthesis (IPP) implant. MAIN OUTCOME MEASURES: Patient demographics, type of IPP, clinical outcomes, post-implant sexual characteristics, and overall patient satisfaction. METHODS: A single-center retrospective review of clinical database and prospective telephone survey were conducted in all men with PD who underwent IPP between January 2006 and November 2010. RESULTS: A total of 138 patients with an average age of 57.7 (32 to 80) underwent AMS 700 CX (88 patients) and Coloplast Titans (50 patients) IPP implantation during the 5-year period. The majority of patients (91%) had only one IPP implantation. The IPP clinical outcomes include eight (6%) revision surgery for device malfunction and three (2%) device explantation for prosthesis infection. While there was no statistically significance in device survival between the two devices, the trend favored AMS 700 CX over Titan (5-year Kaplan-Meier estimates of mechanical survival were 91% vs. 87%, P>0.05) and both IPPs provided similar penile straightening without the need for revision surgery. Most men (79%) reported great satisfaction following CX or Titan implants with greater than two thirds of men reported greater self-confidence and 82% of patients would undergo the same operation again. CONCLUSIONS:AMS 700™ CX and Coloplast™ Titan IPP implantation and penile remodeling appeared to provide permanent penile straightening and high patient satisfaction without an increase risk of revision surgery.
Authors: Nannan Thirumavalavan; Billy H Cordon; Martin S Gross; Jeffrey Taylor; Jean-Francois Eid Journal: J Sex Med Date: 2018-06-05 Impact factor: 3.802
Authors: Jason M Scovell; Liehui Ge; Enrique V Barrera; Steven K Wilson; Rafael E Carrion; Tariq S Hakky Journal: J Sex Med Date: 2016-11 Impact factor: 3.802
Authors: John J Mulcahy; Andrew Kramer; William O Brant; Justin L Parker; Paul E Perito; Jeremy B Myers; Richard Bryson; Meagan Dunne Journal: Curr Urol Rep Date: 2014-06 Impact factor: 3.092